Kelepouris, N., Emir, B., Loftus, J., Rubinstein, E., King, D., & McDonald, M. (2019). SAT-439 Impact on Health Care Resources: A Comparison of Costs Following Treatment with Pegvisomant and Somatostatin Analogues Using Optum Claims Database. J Endocr Soc.
Chicago ZitierstilKelepouris, Nicky, Birol Emir, Jane Loftus, Emily Rubinstein, Donna King, und Margaret McDonald. "SAT-439 Impact On Health Care Resources: A Comparison of Costs Following Treatment With Pegvisomant and Somatostatin Analogues Using Optum Claims Database." J Endocr Soc 2019.
MLA ZitierstilKelepouris, Nicky, et al. "SAT-439 Impact On Health Care Resources: A Comparison of Costs Following Treatment With Pegvisomant and Somatostatin Analogues Using Optum Claims Database." J Endocr Soc 2019.